Page last updated: 2024-08-23

transferrin and Parkinson Disease

transferrin has been researched along with Parkinson Disease in 46 studies

Research

Studies (46)

TimeframeStudies, this research(%)All Research%
pre-19901 (2.17)18.7374
1990's12 (26.09)18.2507
2000's11 (23.91)29.6817
2010's16 (34.78)24.3611
2020's6 (13.04)2.80

Authors

AuthorsStudies
Bandopadhyay, R; Beilina, A; Bonet-Ponce, L; Cookson, MR; Gershlick, DC; Ghosh, MC; Heaton, GR; Kaganovich, A; Kim, C; Kluss, JH; Kumaran, R; Landeck, N; Langston, RG; LaVoie, MJ; Maio, N; Mamais, A; Papazoglou, I; Pellegrini, L; Smith, N1
Devos, D; Dušek, P; Ganapathy S, R; Kalousová, M; Kotačková, L; Levová, K; Rusz, J; Růžička, E; Šonka, K; Trnka, J; Zima, T; Zogala, D1
Katiyar, D; Patel, DK; Sachan, N; Singh, MP; Srikrishna, S; Tiwari, N1
Delgado, DD; Goo, BMSS; Holden, DZY; James, NG; Lee, KD; Nguyen, TPN; Sanstrum, BJ1
Deng, X; Jiang, D; Wang, Y; Zhou, M1
Bailey, DK; Clark, W; Kosman, DJ1
Chan, P; Chen, SD; Du, Y; Guo, P; Hu, Y; Jin, Z; Li, LX; Lian, TH; Piao, YS; Wang, F; Wang, RD; Wang, XM; Wang, YJ; Yu, QJ; Yu, SY; Zhang, W; Zhu, RY; Zuo, LJ1
Hashimoto, Y; Honda, T; Hoshi, K; Ito, H; Matsumoto, Y; Saito, K; Yamaguchi, Y1
Shen, Y; Xu, W; Xu, Y; Yuan, Y; Zhang, B; Zhang, H; Zhang, K; Zhi, Y1
Si, QQ; Tong, Q; Yuan, YS; Zhang, K; Zhang, L; Zhi, Y1
Castro, S; De Miranda, BR; Fazzari, M; Greenamyre, JT; Rocha, EM1
Chen, B; Jiang, H; Song, N; Wang, J; Wen, X; Xie, J1
Ahmed, I; Bronstein, JM; Buchanan, DD; Elbaz, A; Loriot, MA; Mellick, GD; Rhodes, SL; Ritz, B; Rotter, JI; Sinsheimer, JS; Taylor, KD1
Cao, CJ; Huang, XY; Liu, Z; Sun, L; Wang, XM; Yu, SY; Zhang, W; Zuo, LJ1
Bucossi, S; Donno, S; Mariani, S; Simonelli, I; Siotto, M; Squitti, R; Ventriglia, M; Vernieri, F1
Baldissarelli, J; Bochi, GV; Cardoso, AM; Chaves, CM; Fighera, MR; Kegler, A; Medeiros, MS; Moresco, RN; Rieder, CR; Santana, D; Schetinger, MR; Schumacher-Schuh, A1
Arai, H; Fukatsu, M; Furukawa, K; Hashimoto, Y; Hoshi, K; Ishii, R; Ito, H; Kato, T; Kikuchi, A; Miyajima, M; Nollet, K; Takeda, A; Tokuda, T; Ugawa, Y; Yamaguchi, Y; Yoshihara, A1
Baksi, S; Singh, N; Tripathi, AK1
Bäckman, L; Håglin, L1
Anderson, M; Betarbet, R; Cheng, D; Chu, CT; Gearing, M; Greenamyre, JT; Gutekunst, CA; Hoffman, EK; Horowitz, MP; Mastroberardino, PG; Na, HM; Peng, J; Taylor, G; Trojanowski, JQ1
Afeseh Ngwa, H; Anantharam, V; Houk, R; Kanthasamy, A; Kanthasamy, AG; Song, C; Witte, T1
Hirsch, EC1
Annesi, F; Annesi, G; Civitelli, D; De Marco, EV; Gambardella, A; Greco, V; Morelli, M; Novellino, F; Paglionico, S; Provenzano, G; Pucci, F; Quattrone, A; Rocca, FE; Salsone, M; Scornaienchi, V; Tarantino, P1
Albahri, Z; Marklová, E; Vališ, M1
Chai, YJ; Chang, S; Kim, D; Lee, SJ; Park, J; Zhao, H1
Agid, Y; Bonnet, AM; Borie, C; Brice, A; Dürr, A; Gasparini, F; Grandchamp, B; Hetet, G; Verpillat, P1
Beard, J; Connor, J; Hentze, MW; Menzies, S; Muckenthaler, M; Thompson, K; Torti, FM; Torti, SV; Wood, T1
Cunningham, S; Hillard, CJ; Kalivendi, SV; Kalyanaraman, B; Kotamraju, S; Shang, T1
Jiang, H; Wang, J; Xie, JX1
Campdelacreu, J; Ezquerra, M; Muñoz, E; Tolosa, E1
Becker, G; Behnke, S; Berg, D; Hochstrasser, H; Krüger, R; Riess, O; Spiegel, J; Tomiuk, J; Walter, U1
Kuiper, M; Mulder, K; van Kamp, GJ; Wolters, EC1
Brickman, CM; Connor, JR; DeMaggio, AJ; Juneau, PL; Kanaley, L; LeWitt, PA; Loeffler, DA; Nguyen, H; Snyder, BS1
Bloxham, CA; Candy, JM; Edwardson, JA; Morris, CM; Omar, S1
Ayuso-Peralta, L; Cabrera-Valdivia, F; Cañizares-Liébana, F; Codoceo, R; Férnandez-Calle, P; Jiménez-Jiménez, FJ; Larumbe-Lobalde, S; Molina, JA; Rabasa, M; Vázquez, A1
Brickman, CM; DeMaggio, AJ; Finkelman, JH; Juneau, PL; LeWitt, PA; Loeffler, DA; Mashour, GA; Pomara, N1
Beard, JL; Connor, JR; Jones, BC1
Agid, Y; Faucheux, BA; Hauw, JJ; Hirsch, EC; Javoy-Agid, F; Mouatt-Prigent, A; Selimi, F; Villares, J1
Agid, Y; Faucheux, BA; Hauw, JJ; Hirsch, EC1
Armstrong, RA; Blair, JA; Hodgkins, PS; Winsper, SJ1
Cote, L; Freyer, G; Graziano, J; Logroscino, G; LoIacono, N; Marder, K; Mayeux, R; Slavkovich, V1
Alfaro, B; Cote, L; Graziano, J; Logroscino, G; Louis, E; Marder, K; Mayeux, R; Mejia, H; Slavkovich, V; Tang, MX1
Faucheux, BA; Hirsch, EC1
Lee, T; Soong, TW; Wang, Y; Zhang, L1
Fogel, W; Grau, AJ; Werle, E; Willig, V1
Ganrot, PO1

Reviews

7 review(s) available for transferrin and Parkinson Disease

ArticleYear
Association of transferrin G258A and transferrin receptor A82G polymorphisms with the risk of Parkinson disease in certain area.
    Medicine, 2020, Nov-25, Volume: 99, Issue:48

    Topics: Alleles; Genetic Predisposition to Disease; Genotype; Humans; Models, Genetic; Parkinson Disease; Polymorphism, Single Nucleotide; Receptors, Transferrin; Transferrin

2020
A unique glycan-isoform of transferrin in cerebrospinal fluid: A potential diagnostic marker for neurological diseases.
    Biochimica et biophysica acta. General subjects, 2017, Volume: 1861, Issue:10

    Topics: alpha-Synuclein; Biomarkers; Choroid Plexus; Dementia; Diagnosis, Differential; Glycosylation; Humans; Hydrocephalus, Normal Pressure; Parkinson Disease; Polysaccharides; Protein Isoforms; Protein Processing, Post-Translational; Transferrin

2017
Interactions between iron and α-synuclein pathology in Parkinson's disease.
    Free radical biology & medicine, 2019, Volume: 141

    Topics: alpha-Synuclein; Dopaminergic Neurons; Ferritins; FMN Reductase; Homeostasis; Humans; Iron; Oxidative Stress; Parkinson Disease; Signal Transduction; Transferrin

2019
[The relationship between iron metabolism in central nervous system and Parkinson's disease].
    Sheng li ke xue jin zhan [Progress in physiology], 2003, Volume: 34, Issue:1

    Topics: Animals; Biological Transport; Central Nervous System; Ceruloplasmin; Ferritins; Humans; Iron; Lactoferrin; Mice; Parkinson Disease; Rats; Receptors, Transferrin; Transferrin

2003
Iron in the brain.
    Nutrition reviews, 1993, Volume: 51, Issue:6

    Topics: Adult; Aging; Alzheimer Disease; Animals; Brain; Child; Child, Preschool; Ferritins; Humans; Infant; Iron; Multiple Sclerosis; Parkinson Disease; Rats; Receptors, Transferrin; Transferrin

1993
Iron metabolism and Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 1998, Volume: 13 Suppl 1

    Topics: Cell Death; Dopamine; Free Radicals; Humans; Hydroxyl Radical; Iron; Lactoferrin; Neurons; Parkinson Disease; Reactive Oxygen Species; Substantia Nigra; Transferrin

1998
Metabolism and possible health effects of aluminum.
    Environmental health perspectives, 1986, Volume: 65

    Topics: Actin Cytoskeleton; Aluminum; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Aneuploidy; Animals; Autoimmune Diseases; Beryllium; Biological Transport; Bone and Bones; Brain; Cations; Cell Division; Cells; Chromium; Connective Tissue; Cytoplasm; DNA; Down Syndrome; Encephalitis; Erythrocytes; Feces; Gallium; Humans; Hypersensitivity; Immunity, Cellular; Indium; Intestinal Absorption; Intestinal Mucosa; Lung; Membrane Lipids; Microtubules; Muscular Dystrophies; Nondisjunction, Genetic; Osteomalacia; Parkinson Disease; Renal Dialysis; Scandium; Tissue Distribution; Transferrin; Yttrium; Zirconium

1986

Other Studies

39 other study(ies) available for transferrin and Parkinson Disease

ArticleYear
Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia.
    PLoS biology, 2021, Volume: 19, Issue:12

    Topics: Aged; Animals; Biological Transport; Corpus Striatum; Gain of Function Mutation; HEK293 Cells; Humans; Iron; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Lysosomes; Male; Mice; Mice, Inbred C57BL; Microglia; Middle Aged; Mutation; Parkinson Disease; Protein Serine-Threonine Kinases; rab GTP-Binding Proteins; Transferrin; Transferrins

2021
Increased Transferrin Sialylation Predicts Phenoconversion in Isolated REM Sleep Behavior Disorder.
    Movement disorders : official journal of the Movement Disorder Society, 2022, Volume: 37, Issue:5

    Topics: Humans; Parkinson Disease; REM Sleep Behavior Disorder; Synucleinopathies; Tomography, Emission-Computed, Single-Photon; Transferrin

2022
Dyshomeostasis of Iron and Its Transporter Proteins in Cypermethrin-Induced Parkinson's Disease.
    Molecular neurobiology, 2023, Volume: 60, Issue:10

    Topics: Animals; Ceruloplasmin; Copper; Hepcidins; Humans; Iron; Magnesium; Molecular Docking Simulation; Parkinson Disease; Pesticides; Rats; Substantia Nigra; Transferrin; Zinc

2023
Fluctuation Imaging of LRRK2 Reveals that the G2019S Mutation Alters Spatial and Membrane Dynamics.
    Molecules (Basel, Switzerland), 2020, May-31, Volume: 25, Issue:11

    Topics: Adaptor Proteins, Signal Transducing; Cell Line, Tumor; Cell Membrane; Clathrin; Cytosol; Endocytosis; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Microscopy, Confocal; Mutation; Parkinson Disease; Phosphorylation; Protein Domains; Transferrin

2020
The iron chelator, PBT434, modulates transcellular iron trafficking in brain microvascular endothelial cells.
    PloS one, 2021, Volume: 16, Issue:7

    Topics: Alzheimer Disease; Animals; Antigens, CD; Biological Transport; Blood-Brain Barrier; Brain; Cell Membrane; Ceruloplasmin; Endothelial Cells; Ferritins; Humans; Iron; Iron Chelating Agents; Membrane Proteins; Microcirculation; Parkinson Disease; Quinazolinones; Receptors, Transferrin; Transferrin

2021
Serotonergic dysfunctions and abnormal iron metabolism: Relevant to mental fatigue of Parkinson disease.
    Scientific reports, 2016, Dec-21, Volume: 6, Issue:1

    Topics: Aged; China; Depression; Female; Humans; Iron; Male; Mental Fatigue; Middle Aged; Parkinson Disease; Serotonin; Transferrin

2016
Correlations between abnormal iron metabolism and non-motor symptoms in Parkinson's disease.
    Journal of neural transmission (Vienna, Austria : 1996), 2018, Volume: 125, Issue:7

    Topics: Aged; Anxiety; Biomarkers; Depression; Female; Humans; Iron; Male; Middle Aged; Parkinson Disease; Transferrin

2018
Plasma transferrin level correlates with the tremor-dominant phenotype of Parkinson's disease.
    Neuroscience letters, 2018, 09-25, Volume: 684

    Topics: Aged; Biomarkers; Female; Humans; Iron; Male; Middle Aged; Parkinson Disease; Phenotype; Transferrin; Tremor

2018
Sex Differences in Rotenone Sensitivity Reflect the Male-to-Female Ratio in Human Parkinson's Disease Incidence.
    Toxicological sciences : an official journal of the Society of Toxicology, 2019, 07-01, Volume: 170, Issue:1

    Topics: alpha-Synuclein; Animals; Corpus Striatum; Disease Models, Animal; Dopaminergic Neurons; Female; Humans; Lysosomes; Male; Microglia; Parkinson Disease; Rats; Rats, Inbred Lew; Rotenone; Sex Factors; Substantia Nigra; Transferrin; Tyrosine 3-Monooxygenase

2019
Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin.
    Neurobiology of disease, 2014, Volume: 62

    Topics: Adolescent; Adult; Aged; Case-Control Studies; Female; Genetic Association Studies; Humans; Iron; Male; Middle Aged; Parkinson Disease; Polymorphism, Single Nucleotide; Receptors, Transferrin; Transferrin; Young Adult

2014
Sleep disorders in Parkinson's disease: clinical features, iron metabolism and related mechanism.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Depression; Dinoprostone; Fatigue; Female; Humans; Iron; Lactoferrin; Male; Middle Aged; Parkinson Disease; Restless Legs Syndrome; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Transferrin; Tumor Necrosis Factor-alpha

2013
Association between sex, systemic iron variation and probability of Parkinson's disease.
    The International journal of neuroscience, 2016, Volume: 126, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Alleles; Case-Control Studies; Ceruloplasmin; Copper; Female; Genotype; Hemochromatosis Protein; Humans; Iron; Male; Middle Aged; Parkinson Disease; Polymorphism, Genetic; Sex Characteristics; Transferrin

2016
Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.
    PloS one, 2016, Volume: 11, Issue:1

    Topics: 5'-Nucleotidase; Adenosine Deaminase; Adenosine Triphosphatases; Advanced Oxidation Protein Products; Aged; Ascorbic Acid; Biomarkers; Case-Control Studies; Catalase; Dopaminergic Neurons; Female; Ferritins; Humans; Iron; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; Pars Compacta; Peroxidase; Reactive Nitrogen Species; Reactive Oxygen Species; Sulfhydryl Compounds; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Transferrin

2016
Subgroup differences in 'brain-type' transferrin and α-synuclein in Parkinson's disease and multiple system atrophy.
    Journal of biochemistry, 2016, Volume: 160, Issue:2

    Topics: alpha-Synuclein; Alzheimer Disease; Female; Humans; Male; Parkinson Disease; Protein Isoforms; Transferrin

2016
Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson's disease.
    Free radical biology & medicine, 2016, Volume: 97

    Topics: alpha-Synuclein; Animals; Homeostasis; Iron; Mice, Inbred C57BL; Mice, Knockout; Organ Specificity; Parkinson Disease; Retina; Transferrin

2016
Covariation between plasma phosphate and daytime cortisol in early Parkinson's disease.
    Brain and behavior, 2016, Volume: 6, Issue:12

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Case-Control Studies; Circadian Rhythm; Cognition; Female; Humans; Hydrocortisone; Levodopa; Logistic Models; Male; Malnutrition; Middle Aged; Nutrition Assessment; Parkinson Disease; Phosphates; Serum Albumin; Transferrin

2016
A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease.
    Neurobiology of disease, 2009, Volume: 34, Issue:3

    Topics: Aged; Animals; Dopamine; Electron Transport Complex I; Humans; Iron; Macaca fascicularis; Macaca mulatta; Mitochondria; Neurons; Oxidation-Reduction; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Inbred Lew; Receptors, Transferrin; Rotenone; Signal Transduction; Substantia Nigra; Transferrin

2009
Vanadium induces dopaminergic neurotoxicity via protein kinase Cdelta dependent oxidative signaling mechanisms: relevance to etiopathogenesis of Parkinson's disease.
    Toxicology and applied pharmacology, 2009, Oct-15, Volume: 240, Issue:2

    Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Caspase 3; Caspase 9; Cation Transport Proteins; Cell Line; Cell Survival; Cysteine Proteinase Inhibitors; Cytochromes c; DNA Fragmentation; Dopamine; Dose-Response Relationship, Drug; Environmental Pollutants; Inhibitory Concentration 50; Mesencephalon; Mitochondria; Neurons; Neurotoxicity Syndromes; Oxidative Stress; Parkinson Disease; Protein Kinase C-delta; Rats; Reactive Oxygen Species; RNA Interference; Signal Transduction; Time Factors; Transferrin; Vanadium Compounds

2009
Iron transport in Parkinson's disease.
    Parkinsonism & related disorders, 2009, Volume: 15 Suppl 3

    Topics: Animals; Cation Transport Proteins; Disease Models, Animal; Humans; Iron; Mice; Neuroglia; Oxidative Stress; Parkinson Disease; Substantia Nigra; Transferrin

2009
Association study between four polymorphisms in the HFE, TF and TFR genes and Parkinson's disease in southern Italy.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2011, Volume: 32, Issue:3

    Topics: Adult; Aged; Case-Control Studies; Female; Gene Frequency; Genetic Association Studies; Genotype; Hemochromatosis Protein; Histocompatibility Antigens Class I; Humans; Italy; Male; Membrane Proteins; Middle Aged; Parkinson Disease; Polymorphism, Genetic; Receptors, Transferrin; Transferrin

2011
Microheterogeneity of some serum glycoproteins in neurodegenerative diseases.
    Journal of the neurological sciences, 2012, Mar-15, Volume: 314, Issue:1-2

    Topics: Adult; Age Factors; Aged; Aging; Alleles; alpha 1-Antitrypsin; Alzheimer Disease; Apolipoprotein C-III; Apolipoproteins E; Child; Czech Republic; Dementia, Vascular; Female; Gene Frequency; Glycoproteins; Glycosylation; Humans; Isoelectric Focusing; Male; Middle Aged; Neurodegenerative Diseases; Parkinson Disease; Sex Factors; Transferrin

2012
The secreted oligomeric form of α-synuclein affects multiple steps of membrane trafficking.
    FEBS letters, 2013, Mar-01, Volume: 587, Issue:5

    Topics: alpha-Synuclein; Animals; Cell Line; Chlorocebus aethiops; COS Cells; Culture Media, Conditioned; Dynamins; Endocytosis; Humans; Kinetics; Models, Biological; Molecular Targeted Therapy; Parkinson Disease; Protein Structure, Quaternary; Protein Transport; Receptors, Transferrin; Transferrin

2013
Association study between iron-related genes polymorphisms and Parkinson's disease.
    Journal of neurology, 2002, Volume: 249, Issue:7

    Topics: Age of Onset; Aged; Case-Control Studies; DNA Primers; Genotype; Humans; Iron; Middle Aged; Parkinson Disease; Polymerase Chain Reaction; Polymorphism, Genetic; Transferrin

2002
Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress.
    Journal of neuroscience research, 2003, Jan-01, Volume: 71, Issue:1

    Topics: Alzheimer Disease; Animals; Apoferritins; bcl-2-Associated X Protein; Brain; Caspase 3; Caspases; Cation Transport Proteins; Cerebellar Cortex; Cerebellum; Ceruloplasmin; Corpus Striatum; Disease Models, Animal; Ferritins; Gene Expression Profiling; Gene Targeting; Genotype; Heme Oxygenase (Decyclizing); Hippocampus; Immunochemistry; Iron; Iron Deficiencies; Iron-Binding Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Oxidative Stress; Parkinson Disease; Phenotype; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, Transferrin; Superoxide Dismutase; Transferrin

2003
1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide.
    The Biochemical journal, 2003, Apr-01, Volume: 371, Issue:Pt 1

    Topics: 1-Methyl-4-phenylpyridinium; Aconitate Hydratase; Animals; Antioxidants; Apoptosis; Caspase 3; Caspases; Cells, Cultured; Deferoxamine; Edetic Acid; Female; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Humans; Hydrogen Peroxide; Iron; Iron Chelating Agents; Male; Metalloporphyrins; Mitochondria; NADH, NADPH Oxidoreductases; Neurons; Oxidants; Oxidative Stress; Parkinson Disease; Reactive Oxygen Species; Receptors, Transferrin; Staining and Labeling; Transferrin

2003
Association study of the G258S transferrin gene polymorphism and Parkinson's disease in the Spanish population.
    Journal of neurology, 2005, Volume: 252, Issue:10

    Topics: Age of Onset; Alleles; Case-Control Studies; Female; Gene Frequency; Genetics, Population; Humans; Male; Odds Ratio; Parkinson Disease; Polymorphism, Genetic; Spain; Transferrin

2005
Functional relevance of ceruloplasmin mutations in Parkinson's disease.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2005, Volume: 19, Issue:13

    Topics: Alleles; Cell Line; Ceruloplasmin; Endoplasmic Reticulum; Epithelial Cells; Ferritins; Fluorescent Antibody Technique, Indirect; Glycosylation; Glycosylphosphatidylinositols; Heterozygote; Humans; Immunoprecipitation; Iron; Kidney; Microscopy, Fluorescence; Mutation; Mutation, Missense; Neurodegenerative Diseases; Oxidative Stress; Parkinson Disease; Protein Denaturation; Protein Folding; Protein Isoforms; Substantia Nigra; Transfection; Transferrin

2005
Changed transferrin sialylation in Parkinson's disease.
    Clinica chimica acta; international journal of clinical chemistry, 1995, Mar-31, Volume: 235, Issue:2

    Topics: Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Parkinson Disease; Sialic Acids; Transferrin

1995
Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions.
    Journal of neurochemistry, 1995, Volume: 65, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cadaver; Female; Humans; Iron; Male; Middle Aged; Osmolar Concentration; Parkinson Disease; Reference Values; Transferrin

1995
Transferrin receptors in the parkinsonian midbrain.
    Neuropathology and applied neurobiology, 1994, Volume: 20, Issue:5

    Topics: Adult; Aged; Autoradiography; Binding Sites; Female; Humans; Male; Mesencephalon; Parkinson Disease; Receptors, Transferrin; Reference Values; Substantia Nigra; Tissue Distribution; Transferrin

1994
Peripheral iron metabolism in patients with Parkinson's disease.
    Journal of the neurological sciences, 1994, Volume: 125, Issue:1

    Topics: Aged; Circadian Rhythm; Deferoxamine; Female; Ferritins; Humans; Injections, Intramuscular; Iron; Male; Middle Aged; Parkinson Disease; Transferrin

1994
Ceruloplasmin is increased in cerebrospinal fluid in Alzheimer's disease but not Parkinson's disease.
    Alzheimer disease and associated disorders, 1994,Fall, Volume: 8, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Ceruloplasmin; Dementia; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Parkinson Disease; Transferrin

1994
Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease.
    Journal of neurochemistry, 1993, Volume: 60, Issue:6

    Topics: Aged; Aged, 80 and over; Autoradiography; Brain Stem; Humans; Iodine Radioisotopes; Kinetics; Mesencephalon; Neurons; Organ Specificity; Parkinson Disease; Receptors, Transferrin; Reference Values; Transferrin

1993
The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease.
    Brain research, 1997, Feb-21, Volume: 749, Issue:1

    Topics: Aged; Aged, 80 and over; Autoradiography; Binding Sites; Humans; Iodine Radioisotopes; Mesencephalon; Neurons; Parkinson Disease; Substantia Nigra; Transferrin; Ventral Tegmental Area

1997
Gallium-transferrin binding in treated and untreated Parkinson's disease.
    Neuroreport, 1997, Feb-10, Volume: 8, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antiparkinson Agents; Drug Therapy, Combination; Gallium; Humans; Levodopa; Middle Aged; Parkinson Disease; Protein Binding; Selegiline; Transferrin

1997
Altered systemic iron metabolism in Parkinson's disease.
    Neurology, 1997, Volume: 49, Issue:3

    Topics: Aged; Brain; Female; Ferritins; Humans; Iron; Iron Overload; Liver; Male; Parkinson Disease; Receptors, Transferrin; Siderosis; Substantia Nigra; Transferrin

1997
Systemic iron metabolism and mortality from Parkinson's disease.
    Neurology, 1998, Volume: 50, Issue:4

    Topics: Aged; Aged, 80 and over; Female; Ferritins; Humans; Iron; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Predictive Value of Tests; Receptors, Transferrin; Transferrin

1998
Heterologous expression, functional characterization and localization of two isoforms of the monkey iron transporter Nramp2.
    The Biochemical journal, 2000, Jul-01, Volume: 349, Issue:Pt 1

    Topics: 3' Untranslated Regions; Amino Acid Motifs; Amino Acid Sequence; Animals; Base Sequence; Blotting, Southern; Blotting, Western; Calcium; Carrier Proteins; Cation Transport Proteins; Cell Line; Cells, Cultured; Cloning, Molecular; COS Cells; DNA, Complementary; Dose-Response Relationship, Drug; Immunohistochemistry; Iron; Iron-Binding Proteins; Macaca; Membrane Proteins; Molecular Sequence Data; Parkinson Disease; Plasmids; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Distribution; Transfection; Transferrin

2000
Assessment of plasma lactoferrin in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2001, Volume: 16, Issue:1

    Topics: Dopamine; Female; Humans; Lactoferrin; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Substantia Nigra; Transferrin

2001